SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001935979-24-000026
Filing Date
2024-03-18
Accepted
2024-03-18 16:20:03
Documents
22
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A bhvn-20240314.htm   iXBRL DEF 14A 657798
6 bhvn-20240314_g1.jpg GRAPHIC 20335
7 bhvn-20240314_g2.jpg GRAPHIC 84292
8 bhvn-20240314_g3.jpg GRAPHIC 78061
9 bhvn-20240314_g4.jpg GRAPHIC 105754
10 bhvn-20240314_g5.jpg GRAPHIC 106032
11 bhvn-20240314_g6.jpg GRAPHIC 90311
12 bhvn-20240314_g7.jpg GRAPHIC 491713
13 bhvn-20240314_g8.jpg GRAPHIC 174190
  Complete submission text file 0001935979-24-000026.txt   3716696

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20240314.xsd EX-101.SCH 3289
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20240314_def.xml EX-101.DEF 4196
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20240314_lab.xml EX-101.LAB 5400
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20240314_pre.xml EX-101.PRE 3201
25 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20240314_htm.xml XML 63775
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Filer) CIK: 0001935979 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41477 | Film No.: 24759299
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)